Tildrakizumab-asmn Subcutaneous and Timentin Injection
Determining the interaction of Tildrakizumab-asmn Subcutaneous and Timentin Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
Generic Name: clavulanate / ticarcillin
Brand name: Timentin
Synonyms: Ticarcillin and Clavulanate Potassium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tildrakizumab-asmn Subcutaneous-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Timolide
- Tildrakizumab-asmn Subcutaneous-Timolol
- Tildrakizumab-asmn Subcutaneous-Timolol (Systemic)
- Tildrakizumab-asmn Subcutaneous-Timolol and hydrochlorothiazide
- Tildrakizumab-asmn Subcutaneous-Timolol eent
- Timentin Injection-Tilia Fe
- Timentin Injection-Tiludronate
- Timentin Injection-Timentin
- Timentin Injection-Timentin Add-Vantage
- Timentin Injection-Timentin Novaplus
- Timentin Injection-Timolide